(Q33834907)

29 July 2017

1 reference

title

Potential hepatotoxicity of lamotrigine (English)

1 reference

29 July 2017

1 reference

1 reference

M Fayad

1 reference

29 July 2017

R Choueiri

series ordinal

1 reference

29 July 2017

M Mikati

series ordinal

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

49-52

1 reference

Lamotrigine treatment in childhood drug resistant epilepsy.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

Acute hepatic failure in a child treated with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

Lamotrigine for the treatment of epilepsy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

Lamotrigine in absence and primary generalized epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

Long-term tolerability, pharmacokinetic and preliminary efficacy study of lamotrigine in patients with resistant partial seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

Acute effects of lamotrigine (BW430C) in persons with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

Multisystem adverse reaction to lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

Multiorgan failure and disseminated intravascular coagulation in severe convulsive seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900106-X

7 January 2021

10.1016/S0887-8994(99)00106-X

Identifiers

DOI

1 reference

29 July 2017

1 reference